
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59E9529265C2433AE952000DB13C37.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="nar">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229362/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Nucleic Acids Research">
<meta name="citation_title" content="The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination">
<meta name="citation_author" content="Lucia Alvaro-Aranda">
<meta name="citation_author_institution" content="Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain">
<meta name="citation_author" content="Ambre Petitalot">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris 75005, France">
<meta name="citation_author_institution" content="PSL Research University, Paris 75005, France">
<meta name="citation_author" content="Yasmina Djeghmoum">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author" content="Davide Panigada">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author" content="Jenny Kaur Singh">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author" content="Åsa Ehlén">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author" content="Domagoj Vugic">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author" content="Charlotte Martin">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author" content="Simona Miron">
<meta name="citation_author_institution" content="Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France">
<meta name="citation_author" content="Aida Contreras-Perez">
<meta name="citation_author_institution" content="Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain">
<meta name="citation_author" content="Naima Nhiri">
<meta name="citation_author_institution" content="Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France">
<meta name="citation_author" content="Virginie Boucherit">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author" content="Philippe Lafitte">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris 75005, France">
<meta name="citation_author_institution" content="PSL Research University, Paris 75005, France">
<meta name="citation_author" content="Isaac Dumoulin">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author" content="Francisco Quiles">
<meta name="citation_author_institution" content="Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain">
<meta name="citation_author_institution" content="Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain">
<meta name="citation_author" content="Etienne Rouleau">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris 75005, France">
<meta name="citation_author_institution" content="PSL Research University, Paris 75005, France">
<meta name="citation_author" content="Eric Jacquet">
<meta name="citation_author_institution" content="Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France">
<meta name="citation_author" content="Lidia Feliubadaló">
<meta name="citation_author_institution" content="Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain">
<meta name="citation_author_institution" content="Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain">
<meta name="citation_author" content="Jesús del Valle">
<meta name="citation_author_institution" content="Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain">
<meta name="citation_author_institution" content="Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain">
<meta name="citation_author" content="Shyam K Sharan">
<meta name="citation_author_institution" content="Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, USA">
<meta name="citation_author" content="Dominique Stoppa-Lyonnet">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris 75005, France">
<meta name="citation_author_institution" content="Paris-Cité University, Paris, France">
<meta name="citation_author_institution" content="INSERM U830, Institut Curie, Paris 75005, France">
<meta name="citation_author" content="Sophie Zinn-Justin">
<meta name="citation_author_institution" content="Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France">
<meta name="citation_author" content="Conxi Lázaro">
<meta name="citation_author_institution" content="Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain">
<meta name="citation_author_institution" content="Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain">
<meta name="citation_author" content="Sandrine M Caputo">
<meta name="citation_author_institution" content="Department of Genetics, Institut Curie, Paris 75005, France">
<meta name="citation_author_institution" content="PSL Research University, Paris 75005, France">
<meta name="citation_author" content="Aura Carreira">
<meta name="citation_author_institution" content="Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain">
<meta name="citation_author_institution" content="Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_author_institution" content="Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France">
<meta name="citation_publication_date" content="2023 Dec 23">
<meta name="citation_volume" content="52">
<meta name="citation_issue" content="12">
<meta name="citation_firstpage" content="6964">
<meta name="citation_doi" content="10.1093/nar/gkad1222">
<meta name="citation_pmid" content="38142462">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229362/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229362/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229362/pdf/gkad1222.pdf">
<meta name="description" content="BRCA2 tumor suppressor protein ensures genome integrity by mediating DNA repair via homologous recombination (HR). This function is executed in part by its canonical DNA binding domain located at the C-terminus (BRCA2CTD), the only folded domain of ...">
<meta name="og:title" content="The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="BRCA2 tumor suppressor protein ensures genome integrity by mediating DNA repair via homologous recombination (HR). This function is executed in part by its canonical DNA binding domain located at the C-terminus (BRCA2CTD), the only folded domain of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229362/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11229362">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1093/nar/gkad1222"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/gkad1222.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11229362%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11229362/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11229362/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229362/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/narlogo.gif" alt="Nucleic Acids Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Nucleic Acids Research" title="Link to Nucleic Acids Research" shape="default" href="https://doi.org/10.1093/nar/gkad1222" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Nucleic Acids Res</button></div>. 2023 Dec 23;52(12):6964–6976. doi: <a href="https://doi.org/10.1093/nar/gkad1222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1093/nar/gkad1222</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Nucleic%20Acids%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nucleic%20Acids%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Nucleic%20Acids%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Nucleic%20Acids%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alvaro-Aranda%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Lucia Alvaro-Aranda</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Lucia Alvaro-Aranda</span></h3>
<div class="p">
<sup>1</sup>
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alvaro-Aranda%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lucia Alvaro-Aranda</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Petitalot%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Ambre Petitalot</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Ambre Petitalot</span></h3>
<div class="p">
<sup>2</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div class="p">
<sup>3</sup>
PSL Research University, Paris 75005, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Petitalot%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ambre Petitalot</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Djeghmoum%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yasmina Djeghmoum</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yasmina Djeghmoum</span></h3>
<div class="p">
<sup>4</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>5</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Djeghmoum%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yasmina Djeghmoum</span></a>
</div>
</div>
<sup>4,</sup><sup>5,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Panigada%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Davide Panigada</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Davide Panigada</span></h3>
<div class="p">
<sup>6</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>7</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Panigada%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Davide Panigada</span></a>
</div>
</div>
<sup>6,</sup><sup>7,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Singh%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jenny Kaur Singh</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jenny Kaur Singh</span></h3>
<div class="p">
<sup>8</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>9</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Singh%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jenny Kaur Singh</span></a>
</div>
</div>
<sup>8,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ehl%C3%A9n%20%C3%85%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Åsa Ehlén</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Åsa Ehlén</span></h3>
<div class="p">
<sup>10</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>11</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ehl%C3%A9n%20%C3%85%22%5BAuthor%5D" class="usa-link"><span class="name western">Åsa Ehlén</span></a>
</div>
</div>
<sup>10,</sup><sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vugic%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Domagoj Vugic</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Domagoj Vugic</span></h3>
<div class="p">
<sup>12</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>13</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vugic%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Domagoj Vugic</span></a>
</div>
</div>
<sup>12,</sup><sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martin%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Charlotte Martin</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Charlotte Martin</span></h3>
<div class="p">
<sup>14</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>15</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martin%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Charlotte Martin</span></a>
</div>
</div>
<sup>14,</sup><sup>15</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miron%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Simona Miron</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Simona Miron</span></h3>
<div class="p">
<sup>16</sup>
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miron%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Simona Miron</span></a>
</div>
</div>
<sup>16</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Contreras-Perez%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Aida Contreras-Perez</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Aida Contreras-Perez</span></h3>
<div class="p">
<sup>17</sup>
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Contreras-Perez%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aida Contreras-Perez</span></a>
</div>
</div>
<sup>17</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nhiri%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Naima Nhiri</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Naima Nhiri</span></h3>
<div class="p">
<sup>18</sup>
Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nhiri%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Naima Nhiri</span></a>
</div>
</div>
<sup>18</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boucherit%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Virginie Boucherit</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Virginie Boucherit</span></h3>
<div class="p">
<sup>19</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>20</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boucherit%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Virginie Boucherit</span></a>
</div>
</div>
<sup>19,</sup><sup>20</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lafitte%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Philippe Lafitte</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Philippe Lafitte</span></h3>
<div class="p">
<sup>21</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div class="p">
<sup>22</sup>
PSL Research University, Paris 75005, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lafitte%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Philippe Lafitte</span></a>
</div>
</div>
<sup>21,</sup><sup>22</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dumoulin%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Isaac Dumoulin</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Isaac Dumoulin</span></h3>
<div class="p">
<sup>23</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>24</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dumoulin%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Isaac Dumoulin</span></a>
</div>
</div>
<sup>23,</sup><sup>24</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Quiles%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Francisco Quiles</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Francisco Quiles</span></h3>
<div class="p">
<sup>25</sup>
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain</div>
<div class="p">
<sup>26</sup>
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Quiles%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francisco Quiles</span></a>
</div>
</div>
<sup>25,</sup><sup>26</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rouleau%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Etienne Rouleau</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Etienne Rouleau</span></h3>
<div class="p">
<sup>27</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div class="p">
<sup>28</sup>
PSL Research University, Paris 75005, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rouleau%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Etienne Rouleau</span></a>
</div>
</div>
<sup>27,</sup><sup>28</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jacquet%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Eric Jacquet</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Eric Jacquet</span></h3>
<div class="p">
<sup>29</sup>
Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jacquet%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eric Jacquet</span></a>
</div>
</div>
<sup>29</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feliubadal%C3%B3%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Lidia Feliubadaló</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Lidia Feliubadaló</span></h3>
<div class="p">
<sup>30</sup>
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain</div>
<div class="p">
<sup>31</sup>
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feliubadal%C3%B3%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lidia Feliubadaló</span></a>
</div>
</div>
<sup>30,</sup><sup>31</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22del%C2%A0Valle%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Jesús del Valle</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Jesús del Valle</span></h3>
<div class="p">
<sup>32</sup>
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain</div>
<div class="p">
<sup>33</sup>
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22del%C2%A0Valle%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jesús del Valle</span></a>
</div>
</div>
<sup>32,</sup><sup>33</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sharan%20SK%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Shyam K Sharan</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Shyam K Sharan</span></h3>
<div class="p">
<sup>34</sup>
Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sharan%20SK%22%5BAuthor%5D" class="usa-link"><span class="name western">Shyam K Sharan</span></a>
</div>
</div>
<sup>34</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stoppa-Lyonnet%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Dominique Stoppa-Lyonnet</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Dominique Stoppa-Lyonnet</span></h3>
<div class="p">
<sup>35</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div class="p">
<sup>36</sup>
Paris-Cité University, Paris, France</div>
<div class="p">
<sup>37</sup>
INSERM U830, Institut Curie, Paris 75005, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stoppa-Lyonnet%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dominique Stoppa-Lyonnet</span></a>
</div>
</div>
<sup>35,</sup><sup>36,</sup><sup>37</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zinn-Justin%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Sophie Zinn-Justin</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Sophie Zinn-Justin</span></h3>
<div class="p">
<sup>38</sup>
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zinn-Justin%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sophie Zinn-Justin</span></a>
</div>
</div>
<sup>38</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22L%C3%A1zaro%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Conxi Lázaro</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Conxi Lázaro</span></h3>
<div class="p">
<sup>39</sup>
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain</div>
<div class="p">
<sup>40</sup>
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22L%C3%A1zaro%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Conxi Lázaro</span></a>
</div>
</div>
<sup>39,</sup><sup>40</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caputo%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Sandrine M Caputo</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Sandrine M Caputo</span></h3>
<div class="p">
<sup>41</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div class="p">
<sup>42</sup>
PSL Research University, Paris 75005, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caputo%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sandrine M Caputo</span></a>
</div>
</div>
<sup>41,</sup><sup>42</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carreira%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Aura Carreira</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Aura Carreira</span></h3>
<div class="p">
<sup>43</sup>
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain</div>
<div class="p">
<sup>44</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">
<sup>45</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carreira%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aura Carreira</span></a>
</div>
</div>
<sup>43,</sup><sup>44,</sup><sup>45,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain</div>
<div id="aff2">
<sup>2</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div id="aff3">
<sup>3</sup>
PSL Research University, Paris 75005, France</div>
<div id="aff4">
<sup>4</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff5">
<sup>5</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff6">
<sup>6</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff7">
<sup>7</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff8">
<sup>8</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff9">
<sup>9</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff10">
<sup>10</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff11">
<sup>11</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff12">
<sup>12</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff13">
<sup>13</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff14">
<sup>14</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff15">
<sup>15</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff16">
<sup>16</sup>
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France</div>
<div id="aff17">
<sup>17</sup>
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain</div>
<div id="aff18">
<sup>18</sup>
Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France</div>
<div id="aff19">
<sup>19</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff20">
<sup>20</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff21">
<sup>21</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div id="aff22">
<sup>22</sup>
PSL Research University, Paris 75005, France</div>
<div id="aff23">
<sup>23</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff24">
<sup>24</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff25">
<sup>25</sup>
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain</div>
<div id="aff26">
<sup>26</sup>
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain</div>
<div id="aff27">
<sup>27</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div id="aff28">
<sup>28</sup>
PSL Research University, Paris 75005, France</div>
<div id="aff29">
<sup>29</sup>
Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France</div>
<div id="aff30">
<sup>30</sup>
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain</div>
<div id="aff31">
<sup>31</sup>
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain</div>
<div id="aff32">
<sup>32</sup>
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain</div>
<div id="aff33">
<sup>33</sup>
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain</div>
<div id="aff34">
<sup>34</sup>
Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, USA</div>
<div id="aff35">
<sup>35</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div id="aff36">
<sup>36</sup>
Paris-Cité University, Paris, France</div>
<div id="aff37">
<sup>37</sup>
INSERM U830, Institut Curie, Paris 75005, France</div>
<div id="aff38">
<sup>38</sup>
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France</div>
<div id="aff39">
<sup>39</sup>
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain</div>
<div id="aff40">
<sup>40</sup>
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain</div>
<div id="aff41">
<sup>41</sup>
Department of Genetics, Institut Curie, Paris 75005, France</div>
<div id="aff42">
<sup>42</sup>
PSL Research University, Paris 75005, France</div>
<div id="aff43">
<sup>43</sup>
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain</div>
<div id="aff44">
<sup>44</sup>
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France</div>
<div id="aff45">
<sup>45</sup>
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France</div>
<div class="author-notes p">
<div class="fn" id="COR1">
<sup>✉</sup><p class="display-inline">To whom correspondence should be addressed. Tel: +34 911964497; Email: <span>acarreira@cbm.csic.es</span></p>
</div>
<div class="fn" id="FN1">
<sup>2</sup><p class="display-inline">The first four authors should be regarded as Joint First Authors.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Accepted 2023 Dec 12; Revised 2023 Nov 30; Received 2023 Aug 8; Collection date 2024 Jul 8.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</div>
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by-nc/4.0/</a>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <span>journals.permissions@oup.com</span></p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11229362  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38142462/" class="usa-link">38142462</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>
<strong>This article has been corrected.</strong> See <a href="/articles/PMC11229357/" class="usa-link">Nucleic Acids Res. 2024 Jun 3;52(12):7397</a>.</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>BRCA2 tumor suppressor protein ensures genome integrity by mediating DNA repair via homologous recombination (HR). This function is executed in part by its canonical DNA binding domain located at the C-terminus (BRCA2<sub>CTD</sub>), the only folded domain of the protein. Most germline pathogenic missense variants are located in this highly conserved region which binds to single-stranded DNA (ssDNA) and to the acidic protein DSS1. These interactions are essential for the HR function of BRCA2. Here, we report that the variant R2645G, identified in breast cancer and located at the DSS1 interface, unexpectedly increases the ssDNA binding activity of BRCA2<sub>CTD</sub><em>in vitro</em>. Human cells expressing this variant display a hyper-recombination phenotype, chromosomal instability in the form of chromatid gaps when exposed to DNA damage, and increased PARP inhibitor sensitivity. In mouse embryonic stem cells (mES), this variant alters viability and confers sensitivity to cisplatin and Mitomycin C. These results suggest that BRCA2 interaction with ssDNA needs to be tightly regulated to limit HR and prevent chromosomal instability and we propose that this control mechanism involves DSS1. Given that several missense variants located within this region have been identified in breast cancer patients, these findings might have clinical implications for carriers.</p></section><section class="abstract" id="abstract2"><h2>Graphical Abstract</h2>
<figure class="fig xbox font-sm" id="ga1"><h3 class="obj_head">Graphical Abstract.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2683/11229362/508569ef68f6/gkad1222figgra1.jpg" loading="lazy" height="393" width="800" alt="Graphical Abstract"></p>
<div class="p text-right font-secondary"><a href="figure/ga1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="SEC1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Germline missense pathogenic variants affecting a single <em>BRCA2</em> allele predispose individuals to breast and ovarian cancer. BRCA2 is a multifunctional protein and exerts its main tumor-suppressive function in the cell nucleus through its role in DNA repair by homologous recombination (HR). In particular, it mediates the loading of the recombinase RAD51 on ssDNA preventing its assembly on dsDNA, and promoting the formation of an active RAD51 nucleoprotein filament for HR(<a href="#B1" class="usa-link" aria-describedby="B1">1</a>,<a href="#B2" class="usa-link" aria-describedby="B2">2</a>). Consequently, defects in this pathway perturb chromosome integrity (<a href="#B3" class="usa-link" aria-describedby="B3">3</a>).</p>
<p>BRCA2 is a large protein that is mainly disordered (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>). It exhibits one single folded domain between amino acids 2478 and 3184 that binds to ssDNA, hereafter named BRCA2<sub>CTD</sub>, and to the small acidic protein DSS1. Notably, most pathogenic missense variants have been identified in BRCA2<sub>CTD</sub> (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B6" class="usa-link" aria-describedby="B6">6</a>). Thus, studying this region and its interaction with DNA and DSS1 may shed light on the defective mechanisms that are linked to pathogenicity. DSS1 is required for the stability of BRCA2 (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>) and plays important regulatory roles in the oligomerization of BRCA2 and BRCA2 binding to DNA (<a href="#B9" class="usa-link" aria-describedby="B9">9–11</a>). Moreover, DSS1 has been proposed to facilitate the displacement of RPA by RAD51 during HR by reducing the affinity of RPA for ssDNA (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>).</p>
<p>In addition to the canonical BRCA2<sub>CTD</sub>, BRCA2 contains DNA binding motifs in its disordered N-terminus (NTD) and within the C-terminal RAD51 binding region (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>). BRCA2 oligomerizes through various interfaces that are not entirely characterized (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>,<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>) and binding to DSS1 antagonizes this process (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>,<a href="#B15" class="usa-link" aria-describedby="B15">15</a>). The interaction between BRCA2 and DSS1 also regulates BRCA2 localization in the cell due to a nuclear export signal (NES) that is occluded when DSS1 is bound to BRCA2. As such, several BRCA2 variants showing defective DSS1 binding are cytoplasmic, whereas overexpressing DSS1 enhances BRCA2 nuclear localization (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B17" class="usa-link" aria-describedby="B17">17</a>). Here, we report that BRCA2 R2645G, a variant affecting a residue located close to the DSS1 binding site, does not impair DSS1 binding but unexpectedly favors the interaction of BRCA2<sub>CTD</sub> with ssDNA <em>in vitro</em>. Human cells expressing BRCA2 with this variant exhibit a DNA double-strand break (DSB)- hyper-recombination phenotype as revealed in a gene targeting reporter assay (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>) which results in chromosome instability and increased PARPi sensitivity. In addition, mouse embryonic stem cells bearing the same variant display reduced viability and increased sensitivity to MMC and cisplatin. Our results suggest that the interaction of BRCA2 with ssDNA needs to be tightly regulated to prevent excessive recombination. These findings might have clinical implications for carriers of this variant.</p></section><section id="SEC2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="SEC2-1"><h3 class="pmc_sec_title">Site-directed mutagenesis</h3>
<p>Point mutations (R2520L, R2645G, R2659G) were introduced in BRCA2<sub>CTD</sub> (aa 2474–3190) or EGFP-MBP-BRCA2 vector using QuikChange II and QuikChange XL site-directed mutagenesis kit (Agilent Technologies), respectively, as previously described(<a href="#B28" class="usa-link" aria-describedby="B28">28</a>). Mutagenesis primers were designed using the QuickChange Primer Design program and purchased from MWG Eurofins. Mutations R2645G and G25R were introduced in the BAC CTD-2342K5 (generated by Dr Shyam Sharan's lab (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>) and containing the whole human <em>BRCA2</em> gene), by recombineering using galK selection as previously described(<a href="#B34" class="usa-link" aria-describedby="B34">34</a>). All mutations were verified by Sanger sequencing.</p></section><section id="SEC2-2"><h3 class="pmc_sec_title">Cell lines</h3>
<p>The human cell lines HEK293-T cells (gift from Dr Mounira Amor-Gueret) were cultured in DMEM (Eurobio Abcys, Courtaboeuf, France) media containing 25 mM sodium bicarbonate and 2 mM <span class="font-variant-small-caps">l</span>-glutamine supplemented with 10% FBS (EuroBio Abcys). The BRCA2 deficient colorectal adenocarcinoma cell line DLD1 BRCA2<sup>−/−</sup> (HD 105–007) was purchased from Horizon Discovery (Cambridge, England). The cells were cultured in RPMI media (EuroBio Abcys) containing 25 mM sodium bicarbonate and 2 mM L-Glutamine (EuroBio Abcys) supplemented with 10% FBS (EuroBio Abcys). The DLD1 BRCA2<sup>−/−</sup> cells were maintained in growth media containing 0.1 mg/ml hygromycin B (Thermo Fisher Scientific). The stable cell lines of DLD1 BRCA2 deficient cells expressing BRCA2 WT or variants of interest generated in this study were cultured in growth media containing 0.1 mg/ml hygromycin B (Thermo Fisher Scientific) and 1 mg/ml G418 (Sigma-Aldrich).</p>
<p>All cells were cultured at 37°C with 5% CO<sub>2</sub> in a humidified incubator and all cell lines used in this study have been regularly tested for mycoplasma contamination (MycoAlert, Lonza) and genotyped using GenePrint kit (Promega).</p>
<p>PL2F7 mouse embryonic stem cells used in the complementation and viability assays were generated by Dr Shyam Sharan's lab (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>) have both <em>Brca2</em> alleles knocked out: one constitutive and one conditional (<em>Brca2</em><sup>ko/cko</sup>) and are deficient in <em>Hprt</em>.</p></section><section id="SEC2-3"><h3 class="pmc_sec_title">Stable cell line generation</h3>
<p>To generate DLD1 BRCA2<sup>−/−</sup> stable cell lines expressing human BRCA2 variants of interest we transfected one 100 mm plate of DLD1 BRCA2<sup>−/−</sup> cells at 70% of confluence with 10 μg of a plasmid containing human EGFP-MBP-tagged BRCA2 cDNA (carrying the mutation of interest) using TurboFect (Thermo Fisher Scientific) according to manufacturer's instructions; 48 h post-transfection the cells were serial diluted and cultured in media containing 0.1 mg/ml hygromycin B (Thermo Fisher Scientific) and 1 mg/ml G418 (Sigma-Aldrich) for selection. Single-cell colonies were isolated and later expanded and their genomic DNA was extracted to verify the mutation by sequencing. BRCA2 protein levels were detected by Western Blot using BRCA2 antibody (1:1000, OP95, EMD Millipore).</p></section><section id="SEC2-4"><h3 class="pmc_sec_title">Protein expression and purification</h3>
<p>CTD and the mutated forms were co-expressed with DSS1 to ensure the stability of the protein as previously described. <em>E. coli</em> BL21 DE3 cells were transformed and grown at 37°C in 7 l of Terrific Broth and induced with 0.5% arabinose and 1 mM IPTG overnight at optical density 2. The cells were collected in 20 mM Tris–HCl pH 8300 mM NaCl, 10% glycerol, 0.5 mM EDTA, 5 mM β-mercaptoethanol, 1× Protease Inhibitor Cocktail EDTA-free (Roche), 10 mM MgCl<sub>2</sub>, 1× DNase, 0.5 mg/ml Lysozyme (Sigma-Aldrich) and the suspension was lysed by disintegration at 1.7 kbar. The His-tagged protein was incubated with Protino Ni-NTA agarose (Macherey Nagel) and eluted with 200 mM imidazole. After dialysis overnight against 20 mM Tris–HCl pH 8, 100 mM NaCl, 10% glycerol, 0.5 mM EDTA, 5 mM β-mercaptoethanol, the eluate was loaded onto a 5 ml HiTrap Heparin HP column (GE) and eluted using a continuous NaCl gradient (100–1 M NaCl) in the same buffer. When required, the pool of purified protein was reloaded into Protrino Ni-NTA agarose as above. The pool of nuclease-free fractions was dialyzed against a storage buffer containing 20 mM Tris–HCl pH 8, 100 mM NaCl, 10% glycerol, 0.5 mM EDTA and 5 mM β-mercaptoethanol. The protein concentration was determined by NanoDrop 2000 spectrophotometer (Fisher Scientific) and corrected for the contaminants bands by running the protein on a 10% acrylamide SDS PAGE gel and measured by ImageJ software.</p>
<p>His-DSS1 was expressed in the pET-M13 vector and produced in <em>Escherichia coli</em> BL21 (DE3) Star cells. The DSS1 protein expression was induced with 1 mM IPTG at an OD<sub>600</sub> of 0.8 and further incubation of cells for 3h at 37°C. After centrifugation (at 3500 RPM, during 20 min, at 4°C) the cell pellets were resuspended in the lysis buffer (20 mM Tris–HCl, pH 7.5, NaCl 150 mM, 10 mM imidazole) with a 1× of EDTA-free Protease Inhibitor Cocktail (Roche) and disrupted by sonication. The cell lysate was treated with benzonase nuclease and MgCl<sub>2</sub> (5 mM) for 30 min at 4°C and then centrifugated (20 000 RPM) for 20 min at 4°C. The supernatant was filtrated (0.44 μm) and loaded at 1 ml/min on a HisTrap HP 5 ml column (GE Healthcare) which was equilibrated with buffer A (20 mM Tris–HCl, pH 7.5, NaCl 150 mM, 10 mM imidazole). The proteins were eluted with a linear gradient of imidazole from 0 to 100% of buffer B (20 mM Tris–HCl, pH 7.5, NaCl 150 mM, 400 mM imidazole). The purest fractions were pooled and were dialyzed (3.5 kDa) against 20 mM Tris–HCl, pH 7.5, and 150 mM NaCl buffer. The sample was concentrated on an Amicon Ultra Centrifugal Filter Unit (3 kDa cut-off) and injected at 1 ml/min on a HiLoad 10/300 Superdex 75 column (GE Healthcare) equilibrated in 20 mM Tris–HCl, pH 7.5, 150 mM NaCl. The purified protein was analyzed by SDS-PAGE and the concentration was estimated by spectrophotometric measurement of absorbance at 280 nm.</p></section><section id="SEC2-5"><h3 class="pmc_sec_title">Thermostability measurements by fluorescence-based thermal shift assay (FBTSA)</h3>
<p>The FBTSA method was used to monitor the CTD domain thermal denaturation and changes induced by a mutation and/ or a binding event. To measure the thermostability of WT and mutated CTD domain, we mixed 1.5 μg of purified protein in 20 mM Tris–HCl pH 8.0, 150 mM NaCl, 0.5 mM EDTA, 10% glycerol, 5 mM β-mercaptoethanol, and the SYPRO Orange dye (diluted 800-fold from a 5000-fold stock solution, Invitrogen) in a final volume of 20 μl. Each experiment was repeated at least twice, independently. Experiments were carried out in QuantStudio 12KFlex qPCR machine (Applied Biosystems) with a temperature gradient in the range of 10–95°C at 3°C/min. The fluorescence profiles, derivatives, and Tm were determined using the analysis software of the manufacturer.</p></section><section id="SEC2-6"><h3 class="pmc_sec_title">Electrophoretic mobility shift assay</h3>
<p>DNA substrates for EMSA were purchased PAGE-purified from MWG Eurofins. The ssDNA substrate used in EMSA was PAGE purified oAC423 <sup>32</sup>P-labelled at the 5′-end and contained the following sequence: 5′-CTGCTTTATCAAGATAATTTTTCGACTCATCAGAAATATCCGTTTCCTATATTTATTCCTATTATGTTTTATTCATTTACTTATTCTTTATGTTCATTTTTTATATCCTTTACTTTATTTTCTCTGTTTATTCATTTACTTATTTTGTATTATCCTTATCTTATTTA-3′. The proteins were incubated at the indicated concentrations with 2 nM ssDNA <sup>32</sup>P-labelled DNA substrate for 5 min at 37°C in EMSA reaction buffer (25 mM Tris acetate pH 7.5, 1 mM DTT, 1 mM MgCl<sub>2</sub>). For Figure <a href="#F3" class="usa-link">3B</a>, BRCA2<sub>CTD</sub> and DSS1 were incubated for 15 min at 37°C before the incubation with DNA as above. The protein–DNA complexes were resolved on 6% native polyacrylamide gels in 1× TAE buffer (40 mM Tris acetate, 0.5 mM EDTA) at 70 V for 60 min at 4°C. The gels were dried and analyzed with a Typhoon PhosphorImager (Amersham Biosciences) using Image Quant software (GE Healthcare). In all EMSAs, the ratio of DNA–protein complexes was calculated as the percentage of bound DNA compared with the free DNA on each lane.</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11229362_gkad1222fig3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2683/11229362/6c6d7bb70286/gkad1222fig3.jpg" loading="lazy" height="766" width="692" alt="Figure 3."></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The <em>BRCA2 R2645G</em> variant enhances BRCA2<sub>CTD</sub> binding to ssDNA <em>in vitro</em>. (<strong>A</strong>) (Top) Representative EMSA and (bottom) quantification comparing the ssDNA (167 nt) binding activity of BRCA2<sub>CTD</sub> WT, BRCA2<sub>CTD</sub> R2520L and BRCA2<sub>CTD</sub> R2645G at increasing concentrations, as indicated. The data represent the mean from three independent experiments and it was fitted to a single-site binding curve. Error bars, SD. (<strong>B</strong>) (Left) Representative EMSA showing BRCA2<sub>CTD</sub> WT binding to ssDNA (167nt) at the specified concentrations after incubation with 5 μM DSS1, as indicated, for 15 min at 37ºC. (Right) Quantification of (B). The data represent the mean from three independent experiments and it was fitted to a single-site binding curve. Error bars, SD.</p></figcaption></figure></section><section id="SEC2-7"><h3 class="pmc_sec_title">Subcellular fractionation</h3>
<p>DLD1 stable clones expressing EGFP-MBP-BRCA2 WT, R2520L, R2645G or R2659G pellets were resuspended in BADT buffer (10 mM HEPES pH 7.9, 10 mM KCl, 10% glycerol, 1.5 mM MgCl<sub>2</sub>, 0.34 M sucrose, Triton X-100 0.1%) supplemented with 1 × protease inhibitor cocktail (Complete, EDTA-free; Roche), 1 mM PMSF, 1 mM DTT, and 0.1 mM Na<sub>3</sub>VO<sub>4</sub>. The cell suspension was incubated for 20 min on ice and the cytoplasmic fraction was separated by centrifugation (supernatant). After a wash with BAD buffer (same as BADT buffer, without Triton X-100), the pellet was resuspended in 1x sample buffer, incubated on ice for 5 min, and sonicated. The two protein fractions were boiled for 5 min, separated by SDS–PAGE, and analyzed by Western blotting using anti-tubulin as a control for the cytoplasmic fraction. For all western blots, the protein bands were visualized with a ChemiDoc XRS+ System (BioRad). Stain-free images of the gels before transfer were used as loading control, and the cropped image is shown in the figure.</p></section><section id="SEC2-8"><h3 class="pmc_sec_title">GFP-trap</h3>
<p>GFP-pulldowns were performed on HEK293T cells transiently transfected with EGFP-MBP-NLS, EGFP-MBP-BRCA2 (WT or the VUS R2645G) and MBP-BRCA2-WT-RFP. Cells were lysed 36–48 h later in Co-IP lysis buffer (250 mM NaCl, 20 mM HEPES, 0.5% NP-40, 2 mM EGTA, 1.5 mM MgCl<sub>2</sub>, 10% Glycerol, 1 mM DTT and 100 mM PMSF and protease inhibitor cocktail tablets) with or without 500 units benzonase, as indicated in the legends. Samples were incubated for 1 h at 4 °C under constant mixing. A 50 μg input sample was collected in a separate tube and mixed with 6x Laemmli buffer. The cleared lysates were subjected to GFP pull-down with GFP-Trap beads (Chromotek) for 2 h at 4°C. Around 3 mg of total protein, lysate was used per pull-down. The beads were then washed 5 times with Co-IP wash buffer (250 mM NaCl, 20 mM HEPES, 0.5% NP-40, 2 mM EGTA, 1.5 mM MgCl<sub>2</sub>, 10% glycerol, 1 mM DTT and 100 mM PMSF and protease inhibitor cocktail tablets) and boiled for 5 min at 95°C in 3× Laemmli buffer along with the input samples. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 4–12% pre-cast polyacrylamide gels (Invitrogen) (<a href="#sup1" class="usa-link">Supplementary Figure S3B</a>) or 4–15% precast polyacrylamide gels (BioRad) (<a href="#sup1" class="usa-link">Supplementary Figure S3A</a>) and running buffer (1x Tris-Glycine, 0.1% SDS). The proteins were transferred for 2 h at 0.35 A at 4°C in nitrocellulose membranes. Membranes were scanned and analyzed using an Odyssey Infrared Imaging System (Licor; V3.0) and Image Studio Lite (version 5.2) (<a href="#sup1" class="usa-link">Supplementary Figure S3B</a>) or developed using ECL prime western blotting detection reagent (VWR) and visualized using a ChemiDoc camera (BioRad) (<a href="#sup1" class="usa-link">Supplementary Figure S3A</a>).</p></section><section id="SEC2-9"><h3 class="pmc_sec_title">Antibodies used for western blotting</h3>
<p>Primary antibodies used: mouse anti-BRCA2 (1:1000, OP95, EMD Millipore), mouse anti-αtubulin (1:5000, Cat. GTX628802 Genetex GT114, anti-DSS1 (1:500; sc-28848, Santa Cruz Biotechnology), anti-His (1:1000; Biolegend 9061019), rabbit anti-tRFP (1:1000, AB233, EVROGEN ENZO Life Sciences), mouse anti-GFP (1:1000, 11814460001, Sigma) Horseradish peroxidase (HRP)-conjugated secondary antibodies used were as follows: mouse anti-rabbit IgG-HRP (IB: 1:5000, Cat. sc-2357, Santa Cruz), and goat anti-mouse IgG-HRP (1:10000, Cat. # 115035-003, Interchim). For the Odyssey Infrared Imaging System (Licor; V3.0) secondary CF680 goat anti-rabbit or CF770 goat anti-mouse Ig antibodies (1:5000, Biotium) were used.</p></section><section id="SEC2-10"><h3 class="pmc_sec_title">MTT viability test in human DLD1 cells</h3>
<p>DLD1-derived cell lines were seeded in 96-well plates at different densities and treated 24 h later with different concentrations of PARP inhibitor (Olaparib AZD2281, Ku-0059436, Euromedex) (0, 0.5, 1, 2.5 μM). After 6 days of continuous treatment, cells were treated with 0.5μg/ml MTT (Thiazolyl Blue Tetrazolium Bromide; Sigma-Aldrich) diluted in culture medium, then incubated for 4h at 37°C, 5% CO<sub>2</sub> till the formation of blue crystals. Then the MTT was removed, and the crystals were dissolved in DMSO by shaking the plates for 10 min at RT following manufacturer specifications. The absorbance was measured in a plate reader (TriStar<sup>2</sup> LB 942, BERTHOLD scientific) at 570 nm. The survival percentage was calculated by dividing the absorbance into the cells treated by the absorbance obtained in cells left untreated.</p></section><section id="SEC2-11"><h3 class="pmc_sec_title">BRCA2 complementation assay in mouse embryonic stem (mES) cells</h3>
<p>Since <em>Brca2</em> is essential for the survival of mES cells, PL2F7 <em>Brca2</em><sup>ko/cko</sup> mES cells were used to test the functional effect of <em>BRCA2</em> variants R2645G and G25R with a complementation assay(<a href="#B23" class="usa-link" aria-describedby="B23">23</a>): The <em>BRCA2</em> (mutated and WT) BACs were electroporated into the cells and selected with G418. <em>BRCA2</em> expression was analyzed by RT-PCR and six independent G418<sup>r</sup> clones expressing <em>BRCA2</em> were electroporated with a Pgk-Cre345 plasmid. Thus, the conditional <em>Brca2</em> allele was depleted by the transient expression of Cre recombinase which, at the same time, restored the expression of an inserted <em>Hprt</em>, allowing its selection in the HAT medium. Forty-eight HAT<sup>r</sup> colonies were analyzed by Southern blot to confirm the loss of the BRCA2<sup>cko</sup> allele. HAT<sup>r</sup> colonies were stained with methylene blue.</p></section><section id="SEC2-12"><h3 class="pmc_sec_title">MTT viability test in mouse mES cells</h3>
<p>To test the hypersensitivity of PL2F7 <em>Brca2</em><sup>ko/cko</sup> mES cells transfected with <em>BRCA2</em> mutations R2645G and G25R, cells were seeded in triplicates and treated with the mitomycin C (MMC) or cisplatin at different concentrations as stated in the graphs in Figure <a href="#F2" class="usa-link">2C</a>. Viability was measured with an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2<em>H</em>-tetrazolium bromide) assay 72 h after treatment, as previously described (<a href="#B35" class="usa-link" aria-describedby="B35">35</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11229362_gkad1222fig2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2683/11229362/c99d56810b50/gkad1222fig2.jpg" loading="lazy" height="680" width="750" alt="Figure 2."></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The <em>BRCA2 R2645G</em> variant confers sensitivity to genotoxic agents. (<strong>A</strong>) Quantification of the relative cell viability monitored by MTT assay in human DLD1 cells upon treatment with increasing doses of the PARP inhibitor Olaparib, as indicated. The data represent the mean ± SD of 2–6 independent experiments. A two-way ANOVA test with Dunnett's multiple comparisons test was used to calculate the statistical significance of differences (<em>P</em>-values show significant differences compared to the BRCA2 WT clone). Only significant values are shown. (<strong>B</strong>) Representative images of methylene blue staining of HAT-resistant colonies of mES cells expressing no BAC, BRCA2 WT or the BRCA2 R2645G variant. (<strong>C</strong>) Quantification of the relative cell viability monitored by an MTT assay upon treatment with increasing doses of the MMC (left) or cisplatin (right), as indicated. The data represent the mean ± SD of three independent experiments. A two-way ANOVA test with Dunnett's multiple comparisons test was used to calculate the statistical significance of differences (the <em>P</em>-values show significant differences compared to the BRCA2 WT clone). Only significant values are shown.</p></figcaption></figure></section><section id="SEC2-13"><h3 class="pmc_sec_title">Homologous recombination (HR) test</h3>
<p>HR analysis was performed as previously described (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>). Briefly, DLD1 cells were seeded one day before transfection at 1–3 × 10<sup>6</sup> cells/plate (depending on the cell line). Cells were co-transfected with TALENs to induce DNA double-strand break at the AAVS1 site in the PPP1R12C locus in the genome and a plasmid encoding a promoter-less mCherry fluorescent protein bearing 800 bp homologous sequences to the AAV1 site on each side. The transfection of 1 × 10<sup>6</sup> cells was performed using AMAXA Nucleofector™ 2b device following manufacturer specifications. Cells were then seeded in 6-well plates, maintained, and analyzed 8 days after transfection by flow cytometry. The percentage of mCherry positive cells was analyzed on a BD FACSAria III (BD Bioscience) using the FACSDiva software and data were analyzed with the FlowJo 10.5 software (Tree Star Inc.). Viable and single cells were gated using forward scatter (FSC-A) and side scatter (SSC-S). To separate single cells from the doublets, singlets were selected using FSC-W(y-axis) plotted against FSC-A(x-axis), mCherry positive cells were detected by plotting mCherry-A(y-axis) against FSC-A(x-axis).</p></section><section id="SEC2-14"><h3 class="pmc_sec_title">Metaphase spreads</h3>
<p>Around 1 × 10<sup>5</sup> and 2 × 10<sup>5</sup> cells depending on the cell line were seeded onto six-well plates on coverslips and treated with Mitomycin C (SIGMA M4287-2MG) (3 μM 1 h at 37°C) and the following day was arrested in metaphase by adding 0.1 μg/ml colcemid (Thermofisher 15212012) for 3 h at 37°C. A hypotonic shock was performed by incubating the cells with pre-warmed 16% FBS in water for 40 min. Following the hypotonic shock, the cells were fixed by adding 1 volume of methanol–acetic acid (3:1) into one volume of 16% FBS for 15 min at RT, then methanol: acetic acid (3:1) into one volume of water for 5 min at RT, then methanol–acetic acid (3:1) 30 min RT, and methanol–acetic acid (3:1) for 15 min 4 °C. DNA was stained with 2% Giemsa (Thermo Fisher 10092013) diluted in Gurr buffer (Thermo Fisher 10582013) for 16 min. Chromosomes were acquired either with a Leica DMRB microscope at ×100 magnification and captured with a SONY DXC 930P camera or with a Zeiss Axioskop 2 plus microscope at ×100 magnification and captured with a Leica DMC6200 camera. Chromosomal aberrations were manually counted using Fiji software. Around 50 metaphases were analyzed for cells of each genotype.</p></section><section id="SEC2-15"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>The total number of experimental replicates, mean, median, and error bars are described in the figure legends. Statistical difference was calculated using a two-way ANOVA test with Dunnett's multiple comparisons tests (Figures <a href="#F2" class="usa-link">2A</a>, <a href="#F2" class="usa-link">C</a>, <a href="#F4" class="usa-link">4A</a>) or Kruskal–Wallis test followed by Dunn's multiple comparison tests (Figure <a href="#F4" class="usa-link">4B</a> and <a href="#sup1" class="usa-link">Supplementary Figure S5</a>). A non-linear regression was used to fit the curves in Figure <a href="#F3" class="usa-link">3A</a> and <a href="#F3" class="usa-link">B</a> and obtain apparent the dissociation constants shown in Table <a href="#tbl2" class="usa-link">2</a>. All analyses were conducted using GraphPad Prism version Mac OS X 10.0.1 (170).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11229362_gkad1222fig4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2683/11229362/6783cd22dbe5/gkad1222fig4.jpg" loading="lazy" height="940" width="715" alt="Figure 4."></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Human DLD1 expressing BRCA2 R2645G exhibit hyper-recombination. (<strong>A</strong>) (left) Scheme of the cell-based HR assay. (Right) Frequency of mCherry positive cells transfected with the promoter-less donor plasmid (AAVS1-2A-mCherry) without (−TALEN) (filled circles) or with (+TALEN) nucleases (open circles). The error bars represent the mean ± SEM of two to four independent experiments. Two-way ANOVA test with Dunnett's multiple comparisons test. The p-values show significant differences compared to the BRCA2 WT clone. (<strong>B</strong>) (top) Schematic representation of the experiment timing and the dose of MMC used to detect chromosomal aberrations and representative images of metaphase spreads of DLD1 BRCA2-deficient cells (BRCA2−/−) or BRCA2−/− cells stably expressing BRCA2 WT or BRCA2-R2645G (c. E8), as indicated, treated with 3 μM MMC for 1h. The type of chromosomal aberrations observed is indicated with numbers and magnified below. (Bottom). Quantification of chromosomal gaps/small breaks from the same cells either left untreated or upon treatment with MMC, as indicated. Data represent the median and 25% and 75% quartiles of three independent experiments where 50 metaphase spreads were analyzed in each experimental data set. Statistical difference was determined by the Kruskal-Wallis test followed by Dunn's multiple comparison test. ns, not significant, *<em>P</em>&lt; 0.05, **<em>P</em>&lt; 0.01, ***<em>P</em>&lt; 0.001, ****<em>P</em>&lt; 0.0001.</p></figcaption></figure><section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>The apparent affinity of BRCA2<sub>CTD</sub>-ssDNA or the indicated variants in the presence or absence of DSS1</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th rowspan="1" colspan="1">Name</th>
<th rowspan="1" colspan="1">
<em>K</em>
<sub>d</sub> (μM)</th>
<th rowspan="1" colspan="1">
<em>K</em>
<sub>d</sub> -DSS1</th>
<th rowspan="1" colspan="1">
<em>K</em>
<sub>d</sub> + DSS1</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> WT</td>
<td rowspan="1" colspan="1">7.5 ± 4.2</td>
<td rowspan="1" colspan="1">5.7 ± 3.6</td>
<td rowspan="1" colspan="1">6.7 ± 2.0</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> R2520L</td>
<td rowspan="1" colspan="1">7.0 ± 2.9</td>
<td rowspan="1" colspan="1">ND</td>
<td rowspan="1" colspan="1">ND</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> R2645G</td>
<td rowspan="1" colspan="1">3.9 ± 1.5</td>
<td rowspan="1" colspan="1">3.4 ± 0.8</td>
<td rowspan="1" colspan="1">3.4 ± 1.3</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T2TFN1"><p>The apparent dissociation constant (<em>K</em><sub>d</sub> app ± SD) for BRCA2<sub>CTD</sub> binding was obtained from fitting the EMSA experiments shown in Figure <a href="#F3" class="usa-link">3A</a> and <a href="#F3" class="usa-link">B</a> (15 min incubation with storage buffer of with DSS1 at 37°C before the addition of DNA) to a one-site binding curve.</p></div></div></section></section></section><section id="SEC3"><h2 class="pmc_sec_title">Results</h2>
<section id="SEC3-1"><h3 class="pmc_sec_title">Variants R2520L and R2645G at the DSS1 interface do not alter BRCA2 nuclear localization</h3>
<p>DSS1 and DNA have been reported as the main regulators of the oligomeric form of BRCA2 <em>in vitro</em> (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>). Moreover, impairing DSS1 interaction as shown in several BRCA2 missense variants, affects the stability of the protein (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>) and exposes a nuclear export signal (NES), which triggers the mislocalization of BRCA2 in the cytoplasm and abrogates its function (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B17" class="usa-link" aria-describedby="B17">17</a>). The negatively charged and disordered DSS1 has been previously hypothesized to mimic DNA, modulating accessibility of DNA binding sites in the BRCA2 Helical domain and OB1 (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>). We set out to characterize BRCA2 missense variants identified in high-risk breast/ovarian cancer patients and predicted to impact DSS1 interaction to shed light on this regulation. We selected three variants of unknown clinical significance (VUS), R2520L (c.7559G &gt; T), R2645G (c.7933A &gt; G) and R2659G (c.7975A &gt; G) affecting three highly conserved residues (<a href="#sup1" class="usa-link">Supplementary Figure S1</a>), located within the helical domain at the interface with DSS1 (Figure <a href="#F1" class="usa-link">1A</a>). Among them, R2659G has been recently classified as pathogenic and R2645G as likely benign(<a href="#B19" class="usa-link" aria-describedby="B19">19</a>), whereas R2520L remains a VUS.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11229362_gkad1222fig1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2683/11229362/a97b885ef26c/gkad1222fig1.jpg" loading="lazy" height="759" width="730" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>BRCA2 variants R2520L and R2645G at the DSS1 interface do not alter BRCA2 nuclear localization. (<strong>A</strong>) (Top) Scheme of BRCA2 showing its main functional domains and the selected VUS. Figure created with BioRender.com. (Bottom) Human model of BRCA2<sub>CTD</sub> based on mouse Brca2<sub>CTD</sub> (1MJE) showing the localization of the residues affected by the selected VUS (in green). In this model, BRCA2<sub>CTD</sub> (in white to dark pink) binds to DSS1 (in blue) and a ssDNA (in black). (<strong>B</strong>) Nuclear/cytoplasmic fractionation of stable clones bearing <em>BRCA2</em> VUS presented in (A).</p></figcaption></figure><p>We generated stable cell lines bearing the selected variants by transfecting the <em>BRCA2</em> cDNA coding for a GFP-MBP-tagged version of BRCA2 full-length protein (BRCA2 WT) as well as the variants R2520L, R2645G or R2659G in DLD1 BRCA2 deficient human cells (hereafter BRCA2<sup>−/−</sup>). In this cell line, both alleles of BRCA2 contain a deletion in exon 11 leading to a premature stop codon after BRC5 and cytoplasmic localization of the truncated form of the protein (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>). Wherever possible, we selected two stable clones of each variant to account for phenotypic differences that could be due to the variability in protein levels among the clones compared to the wildtype counterpart (clone C1, hereafter BRCA2 WT). We then conducted a nuclear/cytoplasmic fractionation and immunoblotted for BRCA2, α-tubulin serving as a cytoplasmic marker. As expected, the majority of endogenous BRCA2 localized to the nucleus and this was also the case in the cells complemented with the BRCA2 WT clone (WT C1). The same pattern was observed with clones B5 and C2 of R2520L and H4 and E8 of R2645G. In contrast, cells expressing R2659G G3 displayed a strong cytoplasmic signal with strongly reduced levels of nuclear protein showing that this variant was largely mislocalized in cells (Figure <a href="#F1" class="usa-link">1B</a>).</p>
<p>Taken together, we produced DLD1 BRCA2 deficient cells stably expressing GFP-MBP-BRCA2 with the variants R2520L, R2645G, and R2659G, and we observed that all except BRCA2 R2659G localized in the nucleus.</p></section><section id="SEC3-2"><h3 class="pmc_sec_title">Variants R2520L and R2645G bind DSS1 but mildly destabilize BRCA2<sub>CTD</sub><em>in vitro</em>
</h3>
<p>A large set of BRCA2 pathogenic mutations at the interface with DSS1 have previously been characterized for their impact on DSS1 binding and nuclear localization in cells (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>). Among them, variants I2627F and R2659T in the HD domain, T2722R, D2723H and G2748D in the OB1 domain showed defective DSS1 binding whereas R3052W in the OB3 domain did not. However, all of these variants altered the nuclear localization of a construct expressing the C-terminal region of BRCA2 that comprised the folded BRCA2<sub>CTD</sub>. To determine the impact of R2520L, R2645G and R2659G on BRCA2 molecular properties, we produced and purified a set of recombinant BRCA2<sub>CTD</sub> variants co-expressed with DSS1 in bacteria (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>), including the 6 previously characterized and our three variants. We then measured their capacity to co-purify with DSS1 and assessed their thermal stability. In the control set of variants, BRCA2<sub>CTD</sub>-R2659T, -T2722R, -D2723H and -G2748D could not be produced as soluble proteins when co-expressed with DSS1 in bacteria. BRCA2<sub>CTD</sub>-I2627F and R3052W were poorly expressed, and their thermal stability was severely decreased (I2627F: 48°C; R3052W: 45.5–51.5°C (mean 49.9) compared to that of the WT domain (55°C)) (Table <a href="#tbl1" class="usa-link">1</a>). Yet, they both co-eluted with DSS1 (<a href="#sup1" class="usa-link">Supplementary Figure S2A, B</a>). In the case of our 3 variants, R2659G was very poorly expressed and could not be properly purified (<a href="#sup1" class="usa-link">Supplementary Figure S2A</a>), whereas R2520L and R2645G were well-expressed, their thermal temperatures were mildly reduced (R2520L: 52°C; R2645G: 54°C (Table <a href="#tbl1" class="usa-link">1</a>, <a href="#sup1" class="usa-link">Supplementary Figure S2C</a>)) and they copurified with DSS1 (<a href="#sup1" class="usa-link">Supplementary Figure S2A</a>, <a href="#sup1" class="usa-link">S2B</a>).</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Thermofluor-based analysis of the thermal stability of BRCA2<sub>CTD</sub> WT and mutated forms that were used in this study</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th rowspan="1" colspan="1">Name</th>
<th rowspan="1" colspan="1">Tm ± SD</th>
<th rowspan="1" colspan="1">Replicates</th>
<th rowspan="1" colspan="1">Δ (MUT - WT)</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> WT</td>
<td align="center" rowspan="1" colspan="1">55.02 ± 0.13</td>
<td rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">0.00</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> R2520L</td>
<td align="center" rowspan="1" colspan="1">52.51 ± 0.20</td>
<td rowspan="1" colspan="1">13</td>
<td align="center" rowspan="1" colspan="1">−2.52</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> I2627F</td>
<td align="center" rowspan="1" colspan="1">47.90 ± 0.10</td>
<td rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">−7.12</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> R2645G</td>
<td align="center" rowspan="1" colspan="1">54.07 ± 0.20</td>
<td rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">−0.95</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> R2659G</td>
<td rowspan="1" colspan="1">ND</td>
<td rowspan="1" colspan="1">ND</td>
<td rowspan="1" colspan="1">ND</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRCA2<sub>CTD</sub> R3052W</td>
<td align="center" rowspan="1" colspan="1">49.87 ± 1.82</td>
<td rowspan="1" colspan="1">19</td>
<td align="center" rowspan="1" colspan="1">−5.15</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T1TFN1"><p>Tm, melting temperature. ND, non-determined.</p></div></div></section><p>Taken together, two of our variants, BRCA2<sub>CTD</sub>-R2520L and -R2645G, copurified with DSS1, suggesting no impaired binding, and showed a mild decrease in thermal stability compared to BRCA2<sub>CTD</sub>-WT. This contrasts with the control variants, BRCA2<sub>CTD</sub>-R3052W and I2627F, which showed significantly lower thermal stability despite their co-elution with DSS1.</p></section><section id="SEC3-3"><h3 class="pmc_sec_title">BRCA2 R2645G variant confers sensitivity to genotoxic agents</h3>
<p>Poly (ADP-ribose) polymerase (PARP) inhibitors, in particular Olaparib, are currently used in the clinic to treat breast and ovarian cancer patients carrying germline (likely) pathogenic variants in <em>BRCA1/2</em> (<a href="#B21" class="usa-link" aria-describedby="B21">21</a>) as they are particularly toxic in HR-deficient cells(<a href="#B22" class="usa-link" aria-describedby="B22">22</a>). To assess the sensitivity to Olaparib of cells bearing the three variants, we performed an MTT assay. The relative viability of DLD1 BRCA2 deficient cells was ∼20% upon a 6-day treatment with the highest Olaparib concentration used (2.5 μM); in contrast, 80% of BRCA2 WT complemented cells remained viable, similar to the cells expressing the endogenous BRCA2 protein (Figure <a href="#F2" class="usa-link">2A</a>). A similar trend was observed for the two clones expressing R2520L. In contrast, cells bearing R2659G, the variant that was found mainly in the cytoplasmic fraction (Figure <a href="#F1" class="usa-link">1B</a>), showed as much sensitivity as the BRCA2 deficient cells. Interestingly, the two clones bearing R2645G displayed an intermediate phenotype.</p>
<p>To confirm the possible impact of the variant R2645G in a different cell system, we used mouse embryonic stem cells (mES) in which the selected variant was introduced by mutagenesis and recombination in a bacterial artificial chromosome (BAC) containing human BRCA2. In these cells, one endogenous allele of mBrca2 is defective whereas the other functional mBrca2 allele is conditionally removed by Cre-recombinase transient transfection (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>). The ability of the mutated BRCA2 form to rescue the lethality of mBrca2 deficiency was then analyzed: BRCA2-R2645G conferred reduced viability in a colony formation assay as compared to the WT counterpart suggesting it partially alters BRCA2 function (Figure <a href="#F2" class="usa-link">2B</a>). Moreover, mES expressing BRCA2-R2645G exhibited hypersensitivity to MMC and cisplatin, comparable to the control BRCA2-G25R, a variant previously shown to display sensitivity to DNA damaging agents and reduced HR (<a href="#B24" class="usa-link" aria-describedby="B24">24</a>) (Figure <a href="#F2" class="usa-link">2C</a>).</p>
<p>Altogether, human DLD1 BRCA2<sup>−/−</sup> cells expressing BRCA2-R2659G showed hypersensitivity to PARPi whereas cells expressing BRCA2-R2520L did not. Cells bearing the variant BRCA2-R2645G exhibited an intermediate sensitivity to PARPi compared to BRCA2 WT complemented cells. In addition, mES cells expressing BRCA2-R2645G displayed compromised viability in a colony formation assay and showed sensitivity to MMC and cisplatin in the same cell system, suggesting a defect in BRCA2 function.</p></section><section id="SEC3-4"><h3 class="pmc_sec_title">The BRCA2 R2645G variant enhances BRCA2<sub>CTD</sub> binding to ssDNA <em>in vitro</em>
</h3>
<p>To reveal the molecular basis of BRCA2-R2645G dysfunction, we next measured the DNA binding capacity of BRCA2<sub>CTD</sub>-R2645G <em>in vitro</em> by Electrophoretic Mobility Shift Assay (EMSA). 5 minutes incubation of a <sup>32</sup>P-labeled 167 nt ssDNA with increasing concentrations of BRCA2<sub>CTD</sub>-WT at 37°C, generated a slower mobility species corresponding to DNA–protein complexes. ssDNA binding activity reached ∼80% of ssDNA–protein complex at the maximum concentration used (7 μM) when run at 4°C. BRCA2<sub>CTD</sub>-R2520L yielded a similar fraction of ssDNA-protein complexes. Strikingly, BRCA2<sub>CTD</sub>-R2645G showed higher apparent affinity (<em>K</em><sub>d</sub> 3.9 versus 7.5 μM) than the BRCA2<sub>CTD</sub>-WT or the mutant BRCA2<sub>CTD</sub>-R2520L (Figure <a href="#F3" class="usa-link">3A</a>, Table <a href="#tbl2" class="usa-link">2</a>). Interestingly, R2645G gave rise to two types of protein-DNA complexes based on their mobility.</p>
<p>DSS1 has been described as a competitor for DNA binding (<a href="#B25" class="usa-link" aria-describedby="B25">25</a>) or promoting the monomeric form of BRCA2 which in turn would favor DNA binding (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>). To test whether DSS1 would compete with the BRCA2<sub>CTD</sub>-DNA complex, we used purified DSS1 from bacteria and performed an EMSA with ssDNA as in Figure <a href="#F3" class="usa-link">3A</a> this time incubating increasing concentrations of BRCA2<sub>CTD</sub> WT or BRCA2<sub>CTD</sub>-R2645G (0.5–7 μM) with or without DSS1 (5 μM) for 15 min at 37°C before adding the DNA. Under these conditions, the apparent affinity was slightly higher for both proteins but still, R2645G showed higher affinity than BRCA2<sub>CTD</sub>-WT, <em>K</em><sub>d</sub> = 3.4 μM and 5.7 μM, respectively (Figure <a href="#F3" class="usa-link">3B</a> and Table <a href="#tbl2" class="usa-link">2</a>), consistent with the previous results (Figure <a href="#F3" class="usa-link">3A</a>). Addition of DSS1 did not substantially affect the BRCA2<sub>CTD</sub>-ssDNA interaction nor did it affect the interaction of BRCA2<sub>CTD</sub>-R2645G with DNA (Figure <a href="#F3" class="usa-link">3B</a>, Table <a href="#tbl2" class="usa-link">2</a>).</p>
<p>Together, these results demonstrate that variant R2645G increases ssDNA binding affinity or DNA binding stability of BRCA2 whereas R2520L supports ssDNA binding as the BRCA2<sub>CTD</sub> WT. Moreover, an excess of DSS1 does not prevent DNA binding by the BRCA2<sub>CTD</sub>.</p></section><section id="SEC3-5"><h3 class="pmc_sec_title">BRCA2 R2645G does not impair BRCA2 self-interacting complex</h3>
<p>BRCA2 forms dimers/multimers <em>in vitro</em> and these multimers have also been observed in cells (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>,<a href="#B26" class="usa-link" aria-describedby="B26">26</a>). Based on previous models (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>), an increase in DNA binding as observed in BRCA2<sub>CTD</sub>-R2645G, is expected to favor the monomeric form of BRCA2. To verify the self-interacting complex in our cell system, we co-transfected human embryonic kidney HEK293T cells with MBP-BRCA2-RFP and GFP-MBP-BRCA2, or with GFP-MBP-NLS (nuclear localization signal) as a control. We then used a GFP-trap to pulldown MBP-BRCA2-RFP. Our results indicated that GFP-MBP-BRCA2 formed a complex with MBP-BRCA2-RFP, whereas this was not the case for the control. Moreover, the complex was not sensitive to benzonase suggesting the interaction is not mediated by DNA/RNA (<a href="#sup1" class="usa-link">Supplementary Figure S3A</a>). We then performed the same experiment with BRCA2 R2645G. However, the level of RFP-BRCA2 WT pulldown by the mutated protein did not significantly differ from the pulldown by BRCA2 WT suggesting that BRCA2 R2645G can form a self-interacting complex with BRCA2 WT in cells (<a href="#sup1" class="usa-link">Supplementary Figure S3B</a>).</p></section><section id="SEC3-6"><h3 class="pmc_sec_title">Cells expressing BRCA2 R2645G exhibit hyper-recombination phenotype</h3>
<p>Given the enhanced ssDNA binding activity of BRCA2<sub>CTD</sub> R2645G, we reasoned that this variant might increase HR levels in cells. Using the stable clones expressing the full-length protein BRCA2 WT or the three variants, we performed a cell-based HR assay. In this assay, co-transfection of two site-specific transcription-activator-like effector nuclease (TALENs) plasmids, along with a promoter-less mCherry plasmid containing homology arms for the AAVS1 locus results in a single DSB in the AAVS1 endogenous locus. Only when the DSB is repaired by HR do the cells express a mCherry fluorescent protein that can be quantified by flow cytometry (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>). As expected, ∼11% of BRCA2 WT cells were mCherry+. In contrast, BRCA2 deficient cells (BRCA2<sup>−/−</sup>) showed an average of 4% of mCherry+ cells, nearly matching the background levels in the absence of TALENs (2.6%). The HR capacity of the two stable clones bearing R2520L was similar to the one of the cells expressing the BRCA2 WT clone (9% and 13%). Strikingly, cells expressing the R2645G variant exhibited an increased HR activity (16% and 21% mCherry+ cells, respectively) compared to BRCA2 WT complemented cells (Figure <a href="#F4" class="usa-link">4A</a>, <a href="#sup1" class="usa-link">Supplementary Figure S4A</a>). This was not due to the differences in the expression levels as the clone that increased the activity the most (E8) showed equivalent BRCA2 protein levels as the BRCA2 WT clone (<a href="#sup1" class="usa-link">Supplementary Figure S4B</a>).</p>
<p>Hyper-recombination may lead to chromosomal aberrations due to the possibility of pairing with homologous sequences that fuel genome instability (<a href="#B27" class="usa-link" aria-describedby="B27">27</a>). To explore this, we prepared chromosome spreads of DLD1 <em>BRCA2</em> deficient cells or bearing BRCA2 WT and BRCA2-R2645G left untreated or challenged with the DNA alkylating agent MMC (3 μM 1h). As expected, <em>BRCA2<sup>−/−</sup></em> displayed increased chromosomal aberrations including radials, breaks, and fusions as compared to the BRCA2 WT cells after MMC treatment (Figure <a href="#F4" class="usa-link">4B</a>). Interestingly, cells expressing BRCA2-R2645G did not significantly increase the number of total aberrations in MMC conditions, however, there was a consistent increase in chromatid gaps (Figure <a href="#F4" class="usa-link">4B</a>), in agreement with the sensitivity to MMC observed in mES cells bearing this variant (Figure <a href="#F2" class="usa-link">2C</a>).</p></section><section id="SEC3-7"><h3 class="pmc_sec_title">Association of R2645G variant with breast, ovarian, and prostate cancer high-risk</h3>
<p>To investigate the potential clinical relevance of the R2645G variant we collected three pedigrees carrying this variant. In them, several first relatives were affected with either breast, ovarian, or prostate cancer in addition to the index case (Figure <a href="#F5" class="usa-link">5A</a>). Unfortunately, no DNA from relatives was available to perform co-segregation analysis, therefore an association of this variant to increased susceptibility to <em>BRCA2</em>-associated cancers will require further investigation.</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11229362_gkad1222fig5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2683/11229362/9527f4f1af92/gkad1222fig5.jpg" loading="lazy" height="920" width="786" alt="Figure 5."></a></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>R2645G segregates with breast cancer in high-risk families. (<strong>A</strong>) Individual pedigrees (A–C) containing the R2645G variant. A number inside an icon indicates the number of individuals. Black filed portions in icons denote report-confirmed cancers, and yellow portions denote unconfirmed cancers. The patient's current age or decease age is indicated under individuals’ icons. Below is the cancer location, histology (where available), and age at diagnosis: BR – breast cancer, Brain – brain tumor, CRC – colorectal cancer, ES – esophageal cancer, HN – head and neck cancer, OV – ovarian cancer, PR – Prostate cancer, Skin – skin cancer; IDC – invasive ductal, MED – medullary, MEL – melanoma, OTHER – other histology (non-serous), SER – serous. Variant carriers are indicated (only index cases were tested). (<strong>B</strong>) Working model: Based on previous literature, the active form of BRCA2 would be a monomer that is favored by its interaction with DSS1(<a href="#B10" class="usa-link" aria-describedby="B10">10</a>). Upon a DSB, BRCA2 WT bound to DSS1 locates and loads RAD51 at the ssDNA/dsDNA junction. This allows the formation of a nucleoprotein filament of RAD51 on ssDNA, the limiting step to promote HR. The variant BRCA2-R2645G makes more stable or higher affinity complexes with ssDNA than the BRCA2 WT protein (which might eventually be released from the DNA); this results in hyper-recombination activity in cells expressing this variant. As a consequence, cells expressing BRCA2-R2645G display a higher frequency of chromosomal instability in the form of chromatid gaps when challenged with MMC and higher sensitivity to different genotoxic agents including PARPi, MMC and cisplatin. Figure created with BioRender.com.</p></figcaption></figure></section></section><section id="SEC4"><h2 class="pmc_sec_title">Discussion</h2>
<p>In this work, we investigated the potential impact of BRCA2 missense variants located in BRCA2<sub>CTD</sub> on DNA binding and DSS1 interaction to shed light on the role of these activities on the HR function of BRCA2. Unexpectedly, we report that R2645G, a variant recently classified as likely benign (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>) and located at the interface with DSS1, increased the ssDNA binding capacity of the BRCA2<sub>CTD</sub> <em>in vitro</em> resulting in hyper-recombination in cells as measured by a cell-based HR reporter assay (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>) and prompting chromosomal instability (Figure <a href="#F5" class="usa-link">5B</a>). This instability instigates moderate to high sensitivity to different DNA damage-inducing agents like PARPi, alkylating agents (cisplatin), or crosslinking agents (MMC). To our knowledge, this is the first example of a <em>BRCA2</em> variant inducing a hyper-recombinant phenotype.</p>
<p>The effect on DNA binding of the variant R2645G was surprising considering the distance of R2645 to the putative DNA binding site inferred from the crystal structure of mouse Brca2<sub>CTD</sub> (PBD 1MJE) (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>) and the human model derived from it (Figure <a href="#F1" class="usa-link">1A</a>). However, the isolated HD and OB1 domain has been reported to bind DNA, although with weak affinity (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>); therefore, it is possible that a structural change in the interface with DSS1 due to the mutation R2645G, reflected by the mild reduction of the thermal stability of the mutated BRCA2<sub>CTD</sub> (Table <a href="#tbl1" class="usa-link">1</a>), facilitates binding of this variant to the DNA. It has been previously suggested that the acidic nature of DSS1 may expose the basic residues of the DSS1-binding groove in the HD and OB1 domains of BRCA2<sub>CTD</sub> (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B7" class="usa-link" aria-describedby="B7">7</a>), thus favoring the interaction with DNA. Thus, it is also possible that this modification influences the balance between DSS1- and DNA- binding.</p>
<p>According to current models, DSS1 regulates monomer-dimer species of BRCA2 which in turn, influence DNA binding. Therefore, we speculate that altering the contact with DSS1 would have an indirect effect on DNA binding through the change in the oligomeric form it produces. However, we could not detect a difference in the self-interaction of BRCA2 by pull-down in cells (<a href="#sup1" class="usa-link">Supplementary Figure S3B</a>). Nonetheless, we cannot exclude a small reduction in the self-interaction of the protein which would not be detectable in our overexpression conditions.</p>
<p>In agreement with the role of human DSS1 in allowing DNA binding (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>), rather than competing with it (<a href="#B25" class="usa-link" aria-describedby="B25">25</a>) we observed virtually no change in the affinity of BRCA2<sub>CTD-</sub>WT- or BRCA2<sub>CTD</sub>-R2645G-ssDNA complex when incubated with DSS1 (Figure <a href="#F3" class="usa-link">3B</a>, Table <a href="#tbl2" class="usa-link">2</a>). We did observe a slight increase in the apparent affinity of both the WT and the mutated form for DNA in this assay most likely due to the incubation of the protein at 37ºC for 15 min before the addition of the DNA.</p>
<p>Remarkably, this work also reveals the destabilizing effect of the pathogenic variants BRCA2<sub>CTD</sub>-I2627F and R3052W (<a href="#sup1" class="usa-link">Supplementary Figure S2C</a>, Table <a href="#tbl1" class="usa-link">1</a>) which could explain their severe phenotype in HR activity (<a href="#B6" class="usa-link" aria-describedby="B6">6</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>) despite their copurification with DSS1 (<a href="#sup1" class="usa-link">Supplementary Figure S2A, B</a>).</p>
<p>Our findings suggest that the activity of BRCA2 binding to DNA requires fine-tuning to keep HR under control, so that variants with altered DNA binding, either decreased or increased, such as R2645G, cause defective HR, and we propose that DSS1 contributes to the regulation of BRCA2 interaction with DNA.</p>
<p>A previous report described that Poly-ADP-Rybosylation (PARylation) of BRCA1 by PARP1 negatively modulates HR activity by decreasing BRCA1 avidity for DNA (<a href="#B29" class="usa-link" aria-describedby="B29">29</a>). They further showed that certain cancer-derived BRCA1-mutated cell lines are defective in BRCA1-PARylation and display a hyper-recombination phenotype. Although BRCA2 is not a target of PARylation, BRCA2<sub>CTD</sub> has been reported to directly bind PAR chains (<a href="#B30" class="usa-link" aria-describedby="B30">30</a>) which could be acting as a negative regulator of the BRCA2-ssDNA complex by direct competition in the cell. Whether the interaction with PAR chains is affected in BRCA2-R2645G or whether or not this interaction modulates DNA binding will require further investigation. Along the same lines, it is known that the control of HR through the dismantling of RAD51 filaments is critical to avoid pairing with homologous sequences outside the sister chromatid or prevent the formation of toxic recombination intermediates(<a href="#B31" class="usa-link" aria-describedby="B31">31</a>). Interestingly, the tumor-associated variant RAD51 G151D was shown to induce a hyper-recombinant phenotype (<a href="#B32" class="usa-link" aria-describedby="B32">32</a>) Thus, the regulation of BRCA2-DNA interaction could be acting as an additional means to control HR.</p>
<p>The phenotype of cells bearing R2645G both in human DLD1 and mES cells suggests that this variant is hypomorphic in cells, which might have clinical consequences for individuals carrying this variant. However, a recent article classified R2645G as likely benign, based on a multifactorial likelihood model (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>). This model was designed to assess high penetrance variants, so it could misleadingly classify a hypomorphic or moderate risk variant as VUS or (likely) benign. Considering all the available data, we would nowadays classify this variant as of uncertain significance given that (i) although rare, it is not absent from population databases; (ii) it scores 0.634 in the widely recognized <em>in silico</em> meta-predictor REVEL, an intermediate value according to ClinGen thresholds (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>) and (iii) the cell-based and <em>in vitro</em> assays presented here demonstrate an impact on function. Intriguingly, the defective mechanism appears to be different from most BRCA2 missense variants. Understanding the clinical implications for <em>BRCA2 R2645G</em> carriers will require an international effort to collect sufficient clinical data and undertake low-penetrance-adapted case-control, family history, or cosegregation studies.</p></section><section id="sec27"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="sup1"><div class="caption p"><span>gkad1222_Supplemental_File</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11229362/bin/gkad1222_supplemental_file.pdf" data-ga-action="click_feat_suppl" class="usa-link">gkad1222_supplemental_file.pdf</a><sup> (6.3MB, pdf) </sup>
</div></div></section></section><section id="ACK1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank all members of Carreira lab for their input on this manuscript. We thank Stacey Stauffer and Eileen Southon for their help with the ES cell work. We are grateful to Charlene Lasgi from the Flow Cytometry platform of Institut Curie, Orsay.</p>
<p>
<em>Author contributions:</em> L.A.-A, A.P., Y.D., D.P., J. K. S., A.E., D.V., C.M., S. M., E.J., S.C., A. C, designed the experiments; L.A.-A, A.P., Y.D., D.P, J. K. S., A.E., D.V., C.M., S. M., A.C-P., N.N., V. B., P.L., I. D., F.Q. performed the experiments; all authors analyzed the data; A.C. wrote the manuscript with input from all the authors and A.C., D.S.L., S.C., S.Z-J., C. L., E.J., and S.K.S. supervised the research. Funding Acquisition, A.C., S.Z-J., C. L., S.C., E. R., D.S.L.</p></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Lucia Alvaro-Aranda, 
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain.</p>
<p>Ambre Petitalot, 
Department of Genetics, Institut Curie, Paris 75005, France; 
PSL Research University, Paris 75005, France.</p>
<p>Yasmina Djeghmoum, 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p>
<p>Davide Panigada, 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p>
<p>Jenny Kaur Singh, 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p>
<p>Åsa Ehlén, 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p>
<p>Domagoj Vugic, 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p>
<p>Charlotte Martin, 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p>
<p>Simona Miron, 
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France.</p>
<p>Aida Contreras-Perez, 
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain.</p>
<p>Naima Nhiri, 
Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France.</p>
<p>Virginie Boucherit, 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p>
<p>Philippe Lafitte, 
Department of Genetics, Institut Curie, Paris 75005, France; 
PSL Research University, Paris 75005, France.</p>
<p>Isaac Dumoulin, 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p>
<p>Francisco Quiles, 
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain; 
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.</p>
<p>Etienne Rouleau, 
Department of Genetics, Institut Curie, Paris 75005, France; 
PSL Research University, Paris 75005, France.</p>
<p>Eric Jacquet, 
Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France.</p>
<p>Lidia Feliubadaló, 
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain; 
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.</p>
<p>Jesús del Valle, 
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain; 
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.</p>
<p>Shyam K Sharan, 
Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, USA.</p>
<p>Dominique Stoppa-Lyonnet, 
Department of Genetics, Institut Curie, Paris 75005, France; 
Paris-Cité University, Paris, France; 
INSERM U830, Institut Curie, Paris 75005, France.</p>
<p>Sophie Zinn-Justin, 
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France.</p>
<p>Conxi Lázaro, 
Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain; 
Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.</p>
<p>Sandrine M Caputo, 
Department of Genetics, Institut Curie, Paris 75005, France; 
PSL Research University, Paris 75005, France.</p>
<p>Aura Carreira, 
Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain; 
Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France; 
Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.</p></section><section id="SEC5"><h2 class="pmc_sec_title">Data availability</h2>
<p>Authors declare that all relevant data are included in the paper and/or its supplementary information files. Correspondence and requests for materials should be addressed to A.C.</p></section><section id="SEC6"><h2 class="pmc_sec_title">Supplementary data</h2>
<p>
<a href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad1222#supplementary-data" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Supplementary Data</a> are available at NAR Online.</p></section><section id="SEC7"><h2 class="pmc_sec_title">Funding</h2>
<p>Agence National de Recherche [ANR-17-CE12-0016]; Institut National du Cancer [INCa-DGOS_8706]; Matmut; Agencia Española de Investigacion (MCIN/AEI) [PID2020-115977RB-I00 to A.C.]; L.A.-A. was funded by an FPI Fellowship from Agencia Española de Investigacion (MCIN/AEI) [PID2020-115977RBI00]; Fondation ARC pour la Recherche sur le cancer and the French Ministry of Education (to D.V.); Fondation pour la Recherche Medicale (FRM) (to I.D.). Funding for open access charge: Institut Curie (Matmut).</p>
<p>
<em>Conflict of interest statement</em>. None declared.</p></section><section id="REF1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="REF1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Carreira A., Hilario J., Amitani I., Baskin R.J., Shivji M.K.K., Venkitaraman A.R., Kowalczykowski S.C.. 
The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51. Cell. 2009; 136:1032–1043.
</cite> [<a href="https://doi.org/10.1016/j.cell.2009.02.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2669112/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19303847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=The%20BRC%20repeats%20of%20BRCA2%20modulate%20the%20DNA-binding%20selectivity%20of%20RAD51&amp;volume=136&amp;publication_year=2009&amp;pages=1032-1043&amp;pmid=19303847&amp;doi=10.1016/j.cell.2009.02.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Jensen R.B., Carreira A., Kowalczykowski S.C.. 
Purified human BRCA2 stimulates RAD51-mediated recombination. Nature. 2010; 467:678–683.
</cite> [<a href="https://doi.org/10.1038/nature09399" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2952063/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20729832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Purified%20human%20BRCA2%20stimulates%20RAD51-mediated%20recombination&amp;volume=467&amp;publication_year=2010&amp;pages=678-683&amp;pmid=20729832&amp;doi=10.1038/nature09399&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Patel K.J., Yu V.P., Lee H., Corcoran A., Thistlethwaite F.C., Evans M.J., Colledge W.H., Friedman L.S., Ponder B.A., Venkitaraman A.R.. 
Involvement of Brca2 in DNA repair. Mol. Cell. 1998; 1:347–357.
</cite> [<a href="https://doi.org/10.1016/s1097-2765(00)80035-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9660919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Involvement%20of%20Brca2%20in%20DNA%20repair&amp;volume=1&amp;publication_year=1998&amp;pages=347-357&amp;pmid=9660919&amp;doi=10.1016/s1097-2765(00)80035-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Julien M., Ghouil R., Petitalot A., Caputo S.M., Carreira A., Zinn-Justin S.. 
Intrinsic disorder and phosphorylation in BRCA2 facilitate tight regulation of multiple conserved binding events. Biomol. 2021; 11:1060.</cite> [<a href="https://doi.org/10.3390/biom11071060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8301801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34356684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomol&amp;title=Intrinsic%20disorder%20and%20phosphorylation%20in%20BRCA2%20facilitate%20tight%20regulation%20of%20multiple%20conserved%20binding%20events&amp;volume=11&amp;publication_year=2021&amp;pages=1060&amp;pmid=34356684&amp;doi=10.3390/biom11071060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Yang H., Jeffrey P.D., Miller J., Kinnucan E., Sun Y., Thoma N.H., Zheng N., Chen P.-L., Lee W.-H., Pavletich N.P.. 
BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science. 2002; 297:1837–1848.
</cite> [<a href="https://doi.org/10.1126/science.297.5588.1837" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12228710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=BRCA2%20function%20in%20DNA%20binding%20and%20recombination%20from%20a%20BRCA2-DSS1-ssDNA%20structure&amp;volume=297&amp;publication_year=2002&amp;pages=1837-1848&amp;pmid=12228710&amp;doi=10.1126/science.297.5588.1837&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Guidugli L., Pankratz V.S., Singh N., Thompson J., Erding C.A., Engel C., Schmutzler R., Domchek S., Nathanson K., Radice P.et al.. 
A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity. Cancer Res. 2013; 73:265–275.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-12-2081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3537884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23108138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=A%20classification%20model%20for%20BRCA2%20DNA%20binding%20domain%20missense%20variants%20based%20on%20homology-directed%20repair%20activity&amp;volume=73&amp;publication_year=2013&amp;pages=265-275&amp;pmid=23108138&amp;doi=10.1158/0008-5472.CAN-12-2081&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Gudmundsdottir K., Lord C.J., Witt E., Tutt A.N.J., Ashworth A.. 
DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells. EMBO Rep. 2004; 5:989–993.
</cite> [<a href="https://doi.org/10.1038/sj.embor.7400255" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1299155/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15359272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Rep.&amp;title=DSS1%20is%20required%20for%20RAD51%20focus%20formation%20and%20genomic%20stability%20in%20mammalian%20cells&amp;volume=5&amp;publication_year=2004&amp;pages=989-993&amp;pmid=15359272&amp;doi=10.1038/sj.embor.7400255&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Li J., Zou C., Bai Y., Wazer D.E., Band V., Gao Q.. 
DSS1 is required for the stability of BRCA2. Oncogene. 2005; 25:1186–1194.</cite> [<a href="https://doi.org/10.1038/sj.onc.1209153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16205630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=DSS1%20is%20required%20for%20the%20stability%20of%20BRCA2&amp;volume=25&amp;publication_year=2005&amp;pages=1186-1194&amp;pmid=16205630&amp;doi=10.1038/sj.onc.1209153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Zhou Q., Kojic M., Cao Z., Lisby M., Mazloum N.A., Holloman W.K.. 
Dss1 interaction with Brh2 as a regulatory mechanism for recombinational repair. Mol. Cell. Biol. 2007; 27:2512–2526.
</cite> [<a href="https://doi.org/10.1128/MCB.01907-06" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1899899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17261595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell.%20Biol.&amp;title=Dss1%20interaction%20with%20Brh2%20as%20a%20regulatory%20mechanism%20for%20recombinational%20repair&amp;volume=27&amp;publication_year=2007&amp;pages=2512-2526&amp;pmid=17261595&amp;doi=10.1128/MCB.01907-06&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Le H.P., Ma X., Vaquero J., Brinkmeyer M., Guo F., Heyer W.-D., Liu J.. 
DSS1 and ssDNA regulate oligomerization of BRCA2. Nucleic Acids Res. 2020; 45:4507–4516.</cite> [<a href="https://doi.org/10.1093/nar/gkaa555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7641332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32609828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=DSS1%20and%20ssDNA%20regulate%20oligomerization%20of%20BRCA2&amp;volume=45&amp;publication_year=2020&amp;pages=4507-4516&amp;pmid=32609828&amp;doi=10.1093/nar/gkaa555&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Zhou Q., Mazloum N., Mao N., Kojic M., Holloman W.K.. 
Dss1 regulates interaction of Brh2 with DNA. Biochemistry. 2009; 48:11929–11938.
</cite> [<a href="https://doi.org/10.1021/bi901775j" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2795026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19919104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Dss1%20regulates%20interaction%20of%20Brh2%20with%20DNA&amp;volume=48&amp;publication_year=2009&amp;pages=11929-11938&amp;pmid=19919104&amp;doi=10.1021/bi901775j&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Zhao W., Vaithiyalingam S., Filippo J.S., Maranon D.G., Jimenez-Sainz J., Fontenay G.V., Kwon Y., Leung S.G., Lu L., Jensen R.B.et al.. 
Promotion of BRCA2-dependent homologous recombination by DSS1 via RPA targeting and DNA mimicry. Mol. Cell. 2015; 59:176–187.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2015.05.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4506714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26145171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Promotion%20of%20BRCA2-dependent%20homologous%20recombination%20by%20DSS1%20via%20RPA%20targeting%20and%20DNA%20mimicry&amp;volume=59&amp;publication_year=2015&amp;pages=176-187&amp;pmid=26145171&amp;doi=10.1016/j.molcel.2015.05.032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Nicolai C.v., Ehlen A., Martin C., Zhang X., Carreira A.. 
A second DNA binding site in human BRCA2 promotes homologous recombination. Nat. Commun. 2016; 7:12813.
</cite> [<a href="https://doi.org/10.1038/ncomms12813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5027613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27628236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=A%20second%20DNA%20binding%20site%20in%20human%20BRCA2%20promotes%20homologous%20recombination&amp;volume=7&amp;publication_year=2016&amp;pages=12813&amp;pmid=27628236&amp;doi=10.1038/ncomms12813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Kwon Y., Rösner H., Zhao W., Selemenakis P., He Z., Kawale A.S., Katz J.N., Rogers C.M., Neal F.E., Shabestari A.B.et al.. 
DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation. Nat. Commun. 2023; 14:432.
</cite> [<a href="https://doi.org/10.1038/s41467-023-36211-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9879961/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36702902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=DNA%20binding%20and%20RAD51%20engagement%20by%20the%20BRCA2%20C-terminus%20orchestrate%20DNA%20repair%20and%20replication%20fork%20preservation&amp;volume=14&amp;publication_year=2023&amp;pages=432&amp;pmid=36702902&amp;doi=10.1038/s41467-023-36211-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
Lee M., Shorthouse D., Mahen R., Hall B.A., Venkitaraman A.R.. 
Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance. Nucleic Acids Res. 2021; 49:5588–5604.
</cite> [<a href="https://doi.org/10.1093/nar/gkab308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8191791/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33978741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=Cancer-causing%20BRCA2%20missense%20mutations%20disrupt%20an%20intracellular%20protein%20assembly%20mechanism%20to%20disable%20genome%20maintenance&amp;volume=49&amp;publication_year=2021&amp;pages=5588-5604&amp;pmid=33978741&amp;doi=10.1093/nar/gkab308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Shahid T., Soroka J., Kong E., Malivert L., McIlwraith M.J., Pape T., West S.C., Zhang X.. 
Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor. Nat. Struct. Mol. Biol. 2014; 21:962–968.
</cite> [<a href="https://doi.org/10.1038/nsmb.2899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4222816/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25282148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Struct.%20Mol.%20Biol.&amp;title=Structure%20and%20mechanism%20of%20action%20of%20the%20BRCA2%20breast%20cancer%20tumor%20suppressor&amp;volume=21&amp;publication_year=2014&amp;pages=962-968&amp;pmid=25282148&amp;doi=10.1038/nsmb.2899&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Jeyasekharan A.D., Liu Y., Hattori H., Pisupati V., Jonsdottir A.B., Rajendra E., Lee M., Sundaramoorthy E., Schlachter S., Kaminski C.F.et al.. 
A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization. Nat. Struct. Mol. Biol. 2013; 20:1191–1198.
</cite> [<a href="https://doi.org/10.1038/nsmb.2666" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3796201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24013206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Struct.%20Mol.%20Biol.&amp;title=A%20cancer-associated%20BRCA2%20mutation%20reveals%20masked%20nuclear%20export%20signals%20controlling%20localization&amp;volume=20&amp;publication_year=2013&amp;pages=1191-1198&amp;pmid=24013206&amp;doi=10.1038/nsmb.2666&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Vugic D., Ehlen A., Carreira A.. 
Monitoring homologous recombination activity in human cells. Methods Mol. Biol. 2021; 2153:115–126.
</cite> [<a href="https://doi.org/10.1007/978-1-0716-0644-5_9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32840776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods%20Mol.%20Biol.&amp;title=Monitoring%20homologous%20recombination%20activity%20in%20human%20cells&amp;volume=2153&amp;publication_year=2021&amp;pages=115-126&amp;pmid=32840776&amp;doi=10.1007/978-1-0716-0644-5_9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
Caputo S.M., Golmard L., Léone M., Damiola F., Guillaud-Bataille M., Revillion F., Rouleau E., Derive N., Buisson A., Basset N.et al.. 
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: a powerful approach. Am J Hum Genetics. 2021; 108:1907–1923.
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2021.09.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8546044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34597585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genetics&amp;title=Classification%20of%20101%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance%20by%20cosegregation%20study:%20a%20powerful%20approach&amp;volume=108&amp;publication_year=2021&amp;pages=1907-1923&amp;pmid=34597585&amp;doi=10.1016/j.ajhg.2021.09.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Hucl T., Rago C., Gallmeier E., Brody J.R., Gorospe M., Kern S.E.. 
A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res. 2008; 68:5023–5030.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-07-6189" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2536704/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18593900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=A%20syngeneic%20variance%20library%20for%20functional%20annotation%20of%20human%20variation:%20application%20to%20BRCA2&amp;volume=68&amp;publication_year=2008&amp;pages=5023-5030&amp;pmid=18593900&amp;doi=10.1158/0008-5472.CAN-07-6189&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Lord C.J., Ashworth A.. 
PARP inhibitors: synthetic lethality in the clinic. Science. 2017; 355:1152–1158.
</cite> [<a href="https://doi.org/10.1126/science.aam7344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6175050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28302823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=PARP%20inhibitors:%20synthetic%20lethality%20in%20the%20clinic&amp;volume=355&amp;publication_year=2017&amp;pages=1152-1158&amp;pmid=28302823&amp;doi=10.1126/science.aam7344&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Bryant H.E., Schultz N., Thomas H.D., Parker K.M., Flower D., Lopez E., Kyle S., Meuth M., Curtin N.J., Helleday T.. 
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005; 434:913–917.
</cite> [<a href="https://doi.org/10.1038/nature03443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15829966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Specific%20killing%20of%20BRCA2-deficient%20tumours%20with%20inhibitors%20of%20poly(ADP-ribose)%20polymerase&amp;volume=434&amp;publication_year=2005&amp;pages=913-917&amp;pmid=15829966&amp;doi=10.1038/nature03443&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Kuznetsov S.G., Liu P., Sharan S.K.. 
Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat. Med. 2008; 14:875–881.
</cite> [<a href="https://doi.org/10.1038/nm.1719" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2640324/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18607349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=Mouse%20embryonic%20stem%20cell-based%20functional%20assay%20to%20evaluate%20mutations%20in%20BRCA2&amp;volume=14&amp;publication_year=2008&amp;pages=875-881&amp;pmid=18607349&amp;doi=10.1038/nm.1719&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Biswas K., Das R., Eggington J.M., Qiao H., North S.L., Stauffer S., Burkett S.S., Martin B.K., Southon E., Sizemore S.C.et al.. 
Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum. Mol. Genet. 2012; 21:3993–4006.
</cite> [<a href="https://doi.org/10.1093/hmg/dds222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3428152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22678057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mol.%20Genet.&amp;title=Functional%20evaluation%20of%20BRCA2%20variants%20mapping%20to%20the%20PALB2-binding%20and%20C-terminal%20DNA-binding%20domains%20using%20a%20mouse%20ES%20cell-based%20assay&amp;volume=21&amp;publication_year=2012&amp;pages=3993-4006&amp;pmid=22678057&amp;doi=10.1093/hmg/dds222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Zhou Q., Kojic M., Holloman W.K.. 
Dss1 release activates DNA binding potential in Brh2. Biochemistry. 2012; 51:9137–9146.
</cite> [<a href="https://doi.org/10.1021/bi3011187" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3617921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23094644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Dss1%20release%20activates%20DNA%20binding%20potential%20in%20Brh2&amp;volume=51&amp;publication_year=2012&amp;pages=9137-9146&amp;pmid=23094644&amp;doi=10.1021/bi3011187&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Sidhu A., Grosbart M., Sánchez H., Verhagen B., Zon N.L.L.v., Ristic D., Rossum-Fikkert S.E.v., Wyman C. 
Conformational flexibility and oligomerization of BRCA2 regions induced by RAD51 interaction. Nucleic Acids Res. 2020; 48:9649–9659.
</cite> [<a href="https://doi.org/10.1093/nar/gkaa648" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7515699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32785644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=Conformational%20flexibility%20and%20oligomerization%20of%20BRCA2%20regions%20induced%20by%20RAD51%20interaction&amp;volume=48&amp;publication_year=2020&amp;pages=9649-9659&amp;pmid=32785644&amp;doi=10.1093/nar/gkaa648&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Malkova A., Haber J.E.. 
Mutations arising during repair of chromosome breaks. Annu. Rev. Genet. 2012; 46:455–473.
</cite> [<a href="https://doi.org/10.1146/annurev-genet-110711-155547" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23146099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Genet.&amp;title=Mutations%20arising%20during%20repair%20of%20chromosome%20breaks&amp;volume=46&amp;publication_year=2012&amp;pages=455-473&amp;pmid=23146099&amp;doi=10.1146/annurev-genet-110711-155547&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Shimelis H., Mesman R.L.S., Nicolai C., Ehlen A., Guidugli L., Martin C., Calléja F.M.G.R., Meeks H., Hallberg E., Hinton J.et al.. 
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res. 2017; 77:2789–2799.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-16-2568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5508554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28283652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=BRCA2%20hypomorphic%20missense%20variants%20confer%20moderate%20risks%20of%20breast%20cancer&amp;volume=77&amp;publication_year=2017&amp;pages=2789-2799&amp;pmid=28283652&amp;doi=10.1158/0008-5472.CAN-16-2568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Hu Y., Petit S.A., Ficarro S.B., Toomire K.J., Xie A., Lim E., Cao S.A., Park E., Eck M.J., Scully R.et al.. 
PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair. Cancer Discov. 2014; 4:1430–1447.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-13-0891" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4258125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25252691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov.&amp;title=PARP1-driven%20poly-ADP-ribosylation%20regulates%20BRCA1%20function%20in%20homologous%20recombination-mediated%20DNA%20repair&amp;volume=4&amp;publication_year=2014&amp;pages=1430-1447&amp;pmid=25252691&amp;doi=10.1158/2159-8290.CD-13-0891&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Zhang F., Shi J., Bian C., Yu X.. 
Poly(ADP-Ribose) mediates the BRCA2-dependent early DNA damage response. CellReports. 2015; 13:678–689.</cite> [<a href="https://doi.org/10.1016/j.celrep.2015.09.040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4794993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26489468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CellReports&amp;title=Poly(ADP-Ribose)%20mediates%20the%20BRCA2-dependent%20early%20DNA%20damage%20response&amp;volume=13&amp;publication_year=2015&amp;pages=678-689&amp;pmid=26489468&amp;doi=10.1016/j.celrep.2015.09.040&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>
Krejci L., Altmannova V., Spirek M., Zhao X.. 
Homologous recombination and its regulation. Nucleic Acids Res. 2012; 40:5795–5818.
</cite> [<a href="https://doi.org/10.1093/nar/gks270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3401455/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22467216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=Homologous%20recombination%20and%20its%20regulation&amp;volume=40&amp;publication_year=2012&amp;pages=5795-5818&amp;pmid=22467216&amp;doi=10.1093/nar/gks270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>
Marsden C.G., Jensen R.B., Zagelbaum J., Rothenberg E., Morrical S.W., Wallace S.S., Sweasy J.B.. 
The tumor-associated variant RAD51 G151D induces a hyper-recombination phenotype. PLos Genet. 2016; 12:e1006208.
</cite> [<a href="https://doi.org/10.1371/journal.pgen.1006208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4981402/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27513445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLos%20Genet.&amp;title=The%20tumor-associated%20variant%20RAD51%20G151D%20induces%20a%20hyper-recombination%20phenotype&amp;volume=12&amp;publication_year=2016&amp;pages=e1006208&amp;pmid=27513445&amp;doi=10.1371/journal.pgen.1006208&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>
Pejaver V., Byrne A.B., Feng B.-J., Pagel K.A., Mooney S.D., Karchin R., O’Donnell-Luria A., Harrison S.M., Tavtigian S.V., Greenblatt M.S.et al.. 
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am. J. Hum. Genet. 2022; 109:2163–2177.
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2022.10.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9748256/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36413997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Calibration%20of%20computational%20tools%20for%20missense%20variant%20pathogenicity%20classification%20and%20ClinGen%20recommendations%20for%20PP3/BP4%20criteria&amp;volume=109&amp;publication_year=2022&amp;pages=2163-2177&amp;pmid=36413997&amp;doi=10.1016/j.ajhg.2022.10.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>
Warming S., Costantino N., Court D.L., Jenkins N.A., Copeland N.G.. 
Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 2005; 33:e36.
</cite> [<a href="https://doi.org/10.1093/nar/gni035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC549575/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15731329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=Simple%20and%20highly%20efficient%20BAC%20recombineering%20using%20galK%20selection&amp;volume=33&amp;publication_year=2005&amp;pages=e36&amp;pmid=15731329&amp;doi=10.1093/nar/gni035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>
Plumb J.A., Milroy R., Kaye S.B.. 
Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 1989; 49:4435–4440.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2743332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Effects%20of%20the%20pH%20dependence%20of%203-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium%20bromide-formazan%20absorption%20on%20chemosensitivity%20determined%20by%20a%20novel%20tetrazolium-based%20assay&amp;volume=49&amp;publication_year=1989&amp;pages=4435-4440&amp;pmid=2743332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>gkad1222_Supplemental_File</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11229362/bin/gkad1222_supplemental_file.pdf" data-ga-action="click_feat_suppl" class="usa-link">gkad1222_supplemental_file.pdf</a><sup> (6.3MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Authors declare that all relevant data are included in the paper and/or its supplementary information files. Correspondence and requests for materials should be addressed to A.C.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Nucleic Acids Research are provided here courtesy of <strong>Oxford University Press</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1093/nar/gkad1222"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/gkad1222.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11229362/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11229362/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11229362%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229362/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11229362/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11229362/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/38142462/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11229362/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/38142462/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11229362/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11229362/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="YmmH5Qb6p0gFRy6bWJvpyDDquDsQ4T7ZAwMURIEEGIKZ2EBccITZ5Lw6BvR37ECu">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
